Patent 7846456 was granted and assigned to Allergan, Inc. on December, 2010 by the United States Patent and Trademark Office.
A method for treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue.